MARKET

GOVX

GOVX

Geovax Labs Inc
NASDAQ
0.3771
-0.0065
-1.69%
After Hours: 0.3879 +0.0108 +2.86% 19:39 12/05 EST
OPEN
0.3900
PREV CLOSE
0.3836
HIGH
0.3933
LOW
0.3650
VOLUME
724.67K
TURNOVER
--
52 WEEK HIGH
2.770
52 WEEK LOW
0.3650
MARKET CAP
11.20M
P/E (TTM)
-0.1918
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GOVX last week (1124-1128)?
Weekly Report · 4d ago
GeoVax Labs Approves Share Issuance and Reverse Split
TipRanks · 11/26 21:38
Weekly Report: what happened at GOVX last week (1117-1121)?
Weekly Report · 11/24 09:40
GeoVax Labs Price Target Cut to $6.00/Share From $9.00 by D. Boral Capital
Dow Jones · 11/19 13:22
GeoVax Labs Is Maintained at Buy by D. Boral Capital
Dow Jones · 11/19 13:22
D. Boral Capital Maintains Buy on Geovax Labs, Lowers Price Target to $6
Benzinga · 11/19 13:12
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX) and 4D Molecular Therapeutics (FDMT)
TipRanks · 11/17 17:01
Weekly Report: what happened at GOVX last week (1110-1114)?
Weekly Report · 11/17 09:41
More
About GOVX
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using proprietary platforms. Its product pipeline includes ongoing human clinical trials for a Covid-19 vaccine and a gene-directed therapy against advanced head and neck cancers. Its additional research and development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan and Marburg), Zika virus and malaria, as well as immunotherapies for multiple solid tumors. The Company’s portfolio of wholly owned, co-owned, and in-licensed intellectual property, stands at over 155 granted or pending patent applications spread over 24 patent families. Its product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02 and others. Its lead infectious disease candidate is GEO-CM04S1, a COVID-19 vaccine targeting high-risk immunocompromised patient populations.

Webull offers Geovax Labs Inc stock information, including NASDAQ: GOVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GOVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GOVX stock methods without spending real money on the virtual paper trading platform.